Current Dutch Practice on Caesarean Sections: Identification of Barriers and Facilitators for Optimal Care
SIMPLE
2 other identifiers
observational
1,000
1 country
20
Brief Summary
Caesarean (CS) delivery rates in the Netherlands increased from 5 to 15% the last 20 years. CSs have no clear benefit for overall neonatal outcome and are associated with higher maternal complications and high costs. Dutch guidelines offer clear recommendations on factors that have a direct effect on the decision to perform a CS. Hypothesis: there is incomplete adherence to the recommendations from the guidelines on CS among Dutch gynaecologists. This study consists of four phases:
- 1.Development of quality indicators: A set of quality indicators regarding the process, structure and outcome of care will be developed according to the RAND-modified Delphi method. A representative, national expert panel consisting of 12 to 15 obstetricians and midwives will participate.
- 2.Current care study: The current Dutch care will be studied in 20 hospitals (N=80 gynaecologists). 1000 files on performed CSs are analyzed regarding the adherence to the developed quality indicators. To get insight into Dutch practices compared to international data, basic obstetrical data will be extracted from the delivery database.
- 3.Barrier analysis: A barrier analysis will be carried out based on the results of the current care study. Two groups of hospitals will be identified in the upper and lower extremes of the 'adherence distribution': 5 hospitals with the lowest and 5 hospitals with the highest adherence scores. Factors that determine the decision to perform a CS or not (barriers and facilitators) will be analyzed in both groups using semi-structured interviews among 15-20 professionals and 15-20 patients. A questionnaire will be used to study the 'prevalence' of these factors among all obstetric gynaecologists in the Netherlands and among 200 patients.
- 4.Controlled before- and-after (CBA) study: Based on the outcomes of the current care study and the barrier analysis, a tailor made implementation strategy will be developed in order to increase adherence to the CS quality indicators. Target groups will be selected with focus on women with both a high incidence of the indicator and low indicator adherence. The strategy will be executed and evaluated in a CBA-study in 12 hospitals (6 intervention, 6 control) in terms of effectiveness, experiences and costs. The sample size will be dependent on the target group and adherence to the quality indicators regarding this target group. These data will be available after performing the current care and the barrier study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 15, 2010
CompletedFirst Posted
Study publicly available on registry
December 16, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedOctober 30, 2012
October 1, 2012
2.8 years
December 15, 2010
October 29, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
1) Development of quality indicators: development of a valid set of quality indicators for measuring current Dutch care on caesarean sections
December 2010 - October 2013
2) Current care study: The main outcome is the adherence to the quality indicators regarding the process, structure and outcome (maternal and fetal) of care
December 2010 - October 2013
3) Barrier and facilitator analysis: Identification of barriers and facilitators to perform a caesarean section
December 2010 - October 2013
4) Controlled before-and-after study: effectiveness of the implementation strategy defined as observed increase in adherence between the intervention and control hospitals and actual CS rates in both groups
December 2010 - October 2013
Secondary Outcomes (4)
1) Development of quality indicators: no secondary outcomes
December 2010 - October 2013
2) Current care study: International comparison
December 2010- October 2013
3) Barrier and facilitator analysis: no secondary outcomes
December 2010-October 2013
4) Controlled before-and-after study: experiences and satisfaction of health care providers and patients with the implementation strategy and applicability and costs of the strategy
December 2010-October 2013
Study Arms (2)
Caesarean section
Vaginal birth (control)
Interventions
An implementation strategy to improve outcome for women in labour will be developed depending on the outcome of the current care study and the barrier and facilitator analysis.The strategy will be executed and evaluated in a controlled before-and-after study in 12 hospitals (6 intervention, 6 control)
Eligibility Criteria
1. Development of quality indicators: 12-15 obstetricians and midwives 2. Current care study: All women (1000) who underwent a CS in one of the 20 participating hospitals during the study period (3-4 months). All hospitals participate in the Dutch consortium and consist of university teaching-, non-university teaching- and non-university-non-teaching hospitals. 3. Barrier analysis: Qualitative: 15-20 professionals and 15-20 patients from the hospitals in the upper and lower extremes of the 'adherence distribution'. Quantitative: obstetricians in the Netherlands and 200 experienced patients. 4. CBA study: depending on the outcome of phase 2 and 3 of the study, the implementation strategy will be designed for a target group with low guideline adherence and high incidence.
You may qualify if:
- A previous caesarean section in a 3-4 month time period.
You may not qualify if:
- Major congenital malformality
- Fetal death prior to onset of delivery
- Duration of pregnancy less than 24 weeks of gestation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (20)
Ziekenhuisgroep Twente
Almelo, Netherlands
Flevo Ziekenhuis
Almere Stad, Netherlands
Meander Medisch Centrum
Amersfoort, Netherlands
Academisch Medisch Centrum
Amsterdam, Netherlands
Gelreziekenhuizen
Apeldoorn, Netherlands
Rijnstate Ziekenhuis
Arnhem, Netherlands
Ijsselland Ziekenhuis
Capelle Aan Den Ijjsel, Netherlands
Catharina-ziekenhuis
Eindhoven, Netherlands
University Medical Centre Groningen
Groningen, Netherlands
Röpcke-Zweers Ziekenhuis
Hardenberg, Netherlands
Atrium Medisch Centrum Parkstad
Heerlen, Netherlands
Elkerliek Ziekenhuis
Helmond, Netherlands
Tergooiziekenhuizen
Hilversum, Netherlands
Maastricht Universitair Medisch Centrum
Maastricht, Netherlands
Universitair Medisch Centrum St. Radboud
Nijmegen, Netherlands
Orbis Medisch Centrum
Sittard, Netherlands
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
Maxima Medisch Centrum
Veldhoven, Netherlands
Sint Jansgasthuis
Weert, Netherlands
Zaans Medisch Centrum
Zaandam, Netherlands
Related Publications (1)
Melman S, Schoorel EN, Dirksen C, Kwee A, Smits L, de Boer F, Jonkers M, Woiski MD, Mol BW, Doornbos JP, Visser H, Huisjes AJ, Porath MM, Delemarre FM, Kuppens SM, Aardenburg R, Van Dooren IM, Vrouenraets FP, Lim FT, Kleiverda G, van der Salm PC, de Boer K, Sikkema MJ, Nijhuis JG, Hermens RP, Scheepers HC. SIMPLE: implementation of recommendations from international evidence-based guidelines on caesarean sections in the Netherlands. Protocol for a controlled before and after study. Implement Sci. 2013 Jan 3;8:3. doi: 10.1186/1748-5908-8-3.
PMID: 23281646DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Hubertina CJ Scheepers, Ph.D.
Maastricht University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2010
First Posted
December 16, 2010
Study Start
December 1, 2010
Primary Completion
October 1, 2013
Last Updated
October 30, 2012
Record last verified: 2012-10